porcin
reproduct
respiratori
syndrom
viru
prrsv
singl
strand
rna
viru
arterivirida
famili
meulenberg
et
al
viru
widespread
caus
diseas
character
abort
stillbirth
increas
prewean
mortal
respiratori
disord
grow
pig
although
prrsv
alon
consid
primari
pathogen
coinfect
bacteri
viral
pathogen
like
porcin
circoviru
type
swine
influenza
porcin
respiratori
coronaviru
mycoplasma
hyopneumonia
streptococcu
sui
commonli
occur
exacerb
clinic
symptom
grow
pig
dorr
et
al
consequ
prrsv
one
signific
caus
econom
loss
swine
industri
worldwid
neumann
et
al
prrsv
show
high
degre
genet
variat
two
genotyp
recogn
repres
two
prototyp
lelystad
viru
european
type
genotyp
prrsv
american
type
genotyp
ii
prrsv
wensvoort
et
al
collin
et
al
european
type
strain
divid
least
three
subtyp
veterinari
microbiolog
paneuropean
subtyp
eastern
european
subtyp
stadejek
et
al
european
subtyp
differ
describ
virul
strain
one
eastern
european
subtyp
strain
lena
describ
virul
subtyp
strain
determin
clinic
manifest
infect
pig
experiment
condit
karniychuk
et
al
mechan
prrsv
strain
exert
virul
unknown
suggest
relat
vivo
replic
capac
tissu
distribut
immunomodulatori
properti
hayn
et
al
johnson
et
al
love
et
al
prrsv
infect
vivo
specif
subset
differenti
macrophag
lung
lymphoid
tissu
placenta
interact
cell
viru
may
influenc
host
immun
respons
comparison
viral
infect
porcin
influenza
viru
porcin
coronaviru
alter
innat
immun
respons
observ
lower
level
ifn
type
infect
prrsv
strain
van
reeth
et
al
adapt
immun
respons
usual
weak
delay
although
abund
virusspecif
antibodi
respons
induc
exhibit
minim
viru
neutral
activ
kimman
et
al
cellmedi
immun
respons
measur
prrsvspecif
ifng
secret
cell
late
compar
pathogen
meier
et
al
consequ
previou
infect
prrsv
may
protect
homolog
reinfect
induct
insuffici
adapt
immun
respons
also
featur
current
modifi
live
prrsv
vaccin
none
european
genotyp
vaccin
market
contain
subtyp
strain
claim
provid
full
protect
murtaugh
genzow
furthermor
genet
divers
prrsv
thought
influenc
efficaci
vaccin
labarqu
et
al
experiment
studi
prrsv
vaccin
often
efficaci
infect
heterolog
strain
diaz
et
al
zuckermann
et
al
darwich
et
al
aid
develop
efficaci
vaccin
improv
knowledg
immun
respons
prrsv
necessari
studi
investig
immun
respons
pig
infect
field
strain
prrsv
use
american
genotyp
strain
meier
et
al
johnson
et
al
kling
et
al
wang
et
al
limit
number
studi
use
european
type
strain
infect
diaz
et
al
mezlaguna
et
al
inform
avail
immunolog
respons
virul
european
subtyp
strain
aim
present
studi
character
immun
respons
infect
two
european
subtyp
strain
belgium
prototyp
lelystadt
huurn
lv
viru
virul
subtyp
strain
lena
subtyp
strain
caus
sever
clinic
sign
mortal
previou
studi
karniychuk
et
al
demonstr
strain
signific
differ
fever
induct
viral
load
ifng
secret
cell
cytokin
level
blood
cell
popul
humor
respons
unrel
secondari
antigen
prrsv
strain
lena
recent
eastern
european
subtyp
prrsv
isol
use
third
passag
porcin
alveolar
macrophag
pam
lena
isol
belarusian
farm
reproduct
respiratori
failur
karniychuk
et
al
strain
belgium
lv
european
subtyp
prrsv
isol
prrsv
strain
belgium
also
describ
strain
strain
isol
stillborn
piglet
deriv
belgian
farm
outbreak
prrsv
associ
reproduct
disord
karniychuk
et
al
strain
use
third
passag
pam
prrsv
strain
lvter
huurn
isol
epizoot
clinic
case
prr
netherland
wensvoort
et
al
strain
use
seventh
passag
pam
sixtyfour
week
old
male
pig
crossbre
great
yorkshir
larg
white
type
dutch
landrac
obtain
prrsvfree
farm
netherland
high
health
statu
pig
confirm
neg
pcr
one
week
prior
transport
sinc
prrsv
coinfect
increas
sever
diseas
caus
postwean
multisystem
wast
syndrom
grauroma
et
al
harmon
genet
background
pig
across
experiment
group
four
male
pig
sixteen
sow
select
evenli
distribut
four
group
four
group
hous
differ
room
isol
unit
room
cloth
footwear
glove
chang
materi
need
sampl
rectal
temperatur
monitor
provid
separ
room
standard
feed
finish
pig
provid
day
pig
unlimit
access
water
one
week
acclimat
pig
inocul
intranas
ml
contain
tissu
cultur
infecti
dose
tcid
either
prrsv
european
subtyp
strain
lena
group
lena
prrsv
european
subtyp
strain
belgium
group
belgium
prrsv
european
subtyp
strain
lvter
huurn
group
lv
equal
volum
pb
group
control
studi
humor
immun
compet
pig
prrsv
infect
four
pig
per
group
immun
intramuscularli
neck
behind
ear
ml
advvaccin
day
post
inocul
pi
inactiv
adv
vaccin
suvaxyn
iaujeszki
kindli
suppli
pfizer
anim
health
vaccin
contain
oilinwat
adjuv
day
pi
four
pig
per
group
euthan
remain
pig
euthan
termin
experi
day
pi
experi
approv
ethic
committe
anim
experi
central
veterinari
institut
wageningen
ur
rectal
temperatur
clinic
sign
record
daili
fever
defin
bodi
temperatur
higher
one
day
two
consecut
day
quantit
assess
sever
diseas
list
eleven
prrsvrelev
criteria
use
tabl
criterion
score
record
either
normal
score
slightli
alter
score
distinct
clinic
sign
score
sever
prrsv
sign
score
score
ad
obtain
total
score
per
pig
per
day
serum
sampl
collect
day
pi
determin
viru
titer
antibodi
level
sampl
store
directli
test
whole
blood
sampl
nonadv
immun
pig
remain
experi
day
pi
collect
paxgenerna
tube
becton
dickinson
compani
day
pi
paxgen
rna
tube
preanalytix
cell
lyse
rna
stabil
sampl
incub
h
room
temperatur
store
rna
isol
heparin
stabil
blood
sampl
collect
day
pi
peripher
blood
mononuclear
cell
pbmc
isol
blood
sampl
use
ifng
elispot
assay
flow
cytometri
isol
pbmc
perform
densiti
gradient
centrifug
use
ml
leucosep
tube
greiner
bioon
brief
heparin
wholeblood
sampl
dilut
equal
volum
pb
ml
dilut
blood
ad
leucosep
tube
cell
separ
tube
centrifug
room
temperatur
min
g
without
brake
cell
suspens
collect
remain
red
blood
cell
lyse
ack
lyse
buffer
contain
nh
cl
mm
khco
mm
na
edta
cell
wash
twice
pb
centrifug
min
g
resuspend
ml
pb
count
coulter
counter
beckman
coulter
sampl
collect
paxgen
blood
rna
tube
thaw
h
room
temperatur
tube
centrifug
g
min
room
temperatur
supernat
discard
pellet
wash
twice
rnasefre
water
pellet
dissolv
ml
trizol
reagent
invitrogen
extract
rna
perform
accord
instruct
manufactur
yield
puriti
rna
assess
use
nanodrop
spectrophotomet
thermo
fisher
scientif
tabl
clinic
score
list
adapt
mittelholz
et
al
categori
score
individu
anim
sum
result
maximum
score
prrsv
isol
serum
perform
pam
cell
obtain
week
old
piglet
prrsvfree
herd
netherland
cell
previous
test
neg
pcr
pam
cell
cultur
plate
greiner
concentr
cellswel
ml
rpmi
medium
supplement
fb
iuml
penicillin
mgml
streptomycin
crpmi
gibco
invitrogen
well
volum
ml
serum
inocul
plate
incub
co
humidifi
atmospher
day
monolay
wash
nacl
solut
dri
frozen
monolay
stain
immuno
peroxidas
monolay
assay
ipma
describ
van
der
linden
et
al
use
dilut
monoclon
antibodi
rural
technolog
nucleocapsid
protein
prrsv
viru
posit
serum
sampl
taken
day
pi
four
nonimmun
pig
remain
experi
day
pi
titrat
serum
dilut
made
fourfold
make
five
decim
dilut
viru
titer
calcul
tcid
use
rber
method
finney
viral
rna
concentr
serum
analyz
qrtpcr
use
standard
curv
rna
isol
ml
serum
use
high
pure
viral
rna
kit
roch
appli
scienc
accord
manufactur
instruct
standard
curv
construct
viru
strain
extract
rna
five
decim
dilut
medium
known
concentr
infecti
viru
rna
isol
nucleic
acid
store
analysi
qrtpcr
onetub
qrtpcr
perform
stratagen
instrument
use
quantitect
probe
rtpcr
kit
qiagen
reaction
mixtur
ml
contain
ml
kitsuppli
enzym
ml
quantitect
mix
mm
primer
fw
gat
gac
rtc
cgg
cay
rev
cag
ttc
ctg
cgc
ctt
mm
probe
famtgc
aat
cga
tcc
aga
cgg
frossard
et
al
rtpcr
done
min
min
twostep
cycl
protocol
use
follow
cycl
analysi
perform
mxpro
softwar
viral
rna
concentr
tcid
equival
per
ml
individu
sampl
calcul
use
standard
curv
prrsvspecif
antibodi
serum
sampl
test
antibodi
elisa
herdchek
prr
idexx
laboratori
accord
manufactur
instruct
sampletoposit
sp
ratio
equal
greater
consid
posit
detect
viru
neutral
antibodi
prrsv
serum
sampl
day
pi
heattreat
min
serial
dilut
ml
volum
test
serum
made
crpmi
equal
volum
homolog
prrsv
strain
contain
tcid
crpmi
ad
serum
dilut
serumviru
mixtur
incub
min
final
pam
cell
ad
well
plate
incub
day
ipma
stain
viru
posit
cell
describ
advspecif
antibodi
respons
detect
use
indirect
elisa
kimman
et
al
titer
sampl
express
log
reciproc
highest
dilut
yield
sp
ratio
number
antigenspecif
ifngsecret
cell
per
pbmc
determin
use
elispot
assay
accord
method
describ
manufactur
use
multiscreen
ht
ip
filter
plate
millipor
briefli
plate
precoat
overnight
mgml
antipig
ifng
mab
bd
pbmc
pbmc
ml
well
plate
dmem
glutamax
tm
medium
supplement
gl
glucos
mm
hepe
fb
iuml
penicillin
mgml
streptomycin
mm
bmercaptoethanol
gibco
invitrogen
pbmc
stimul
h
triplic
well
addit
homolog
prrsv
multipl
infect
moi
concanavalin
mgml
sigma
use
triplic
well
posit
control
cultur
medium
triplic
well
neg
control
mlwell
plate
incub
ml
antipig
ifng
biotinlabel
mab
bd
concentr
mgml
reaction
reveal
sequenti
incub
streptavidinalkalin
phosphatas
enzym
conjug
r
system
bcipnbt
substrat
solut
r
system
number
specif
ifng
secret
cell
determin
use
analyz
cellular
technolog
ltd
calcul
averag
number
spot
triplic
pbmc
cultur
stimul
viru
minu
number
spot
triplic
pbmc
cultur
expos
cultur
medium
data
express
background
correct
number
ifngsecret
cell
per
pbmc
isol
pbmc
transfer
microtit
plate
cell
volum
ml
per
well
centrifug
min
g
cell
tripl
stain
mab
direct
porcin
identif
leukocyt
popul
identif
tcell
subpopul
stain
primari
antibodi
follow
combin
percp
fitc
pe
label
secondari
antibodi
primari
antibodi
use
mous
clone
igg
kirkham
et
al
mous
clone
igg
pescovitz
et
al
mous
clone
igg
koszinowski
mous
recent
identifi
leitner
et
al
clone
igg
abd
serotec
mous
clone
igg
vmrd
mous
clone
igm
abd
serotec
secondari
antibodi
use
rat
antimous
igg
percp
bd
goat
antimous
igg
fitc
southern
biotech
goat
antimous
igg
pe
southern
biotech
goat
antimous
igm
pe
southern
biotech
flow
cytometri
analys
perform
constant
event
number
cell
acquir
facscan
flow
cytomet
use
cellquest
softwar
bd
bioscienc
monocyt
identifi
b
cell
high
summerfield
et
al
cytotox
cell
subpopul
identifi
high
helper
cell
helper
cell
memori
helper
cell
nk
cell
cell
gd
cell
nielsen
et
al
gerner
et
al
although
major
gd
cell
also
exist
cell
gerner
et
al
therefor
refer
popul
gd
cell
number
cell
popul
per
ml
blood
calcul
use
cell
count
edta
stabil
blood
sampl
medon
cell
counter
boul
medic
ab
concentr
ifna
ifng
tnfa
mrna
rna
extract
peripher
blood
sampl
determin
qrtpcr
describ
wichger
schreur
et
al
slight
modif
briefli
ng
total
rna
revers
transcrib
use
random
primer
superscript
iii
promega
appropri
dilut
cdna
amplifi
pcr
reaction
mix
ml
contain
mm
forward
revers
primer
ml
primer
concentr
sybr
green
mix
appli
biosystem
follow
primer
use
forward
primer
attgcatgcttttcctgctgtt
revers
primer
gctgagttatgcactatgcacgtta
ifng
forward
primer
gagcatggatgtgatcaagcaa
revers
primer
cattcagtttcccagagctacca
forward
primer
agagtctcgttcgttatcggaatt
revers
primer
tgcatggccgttcttagttg
primer
sequenc
obtain
wichger
schreur
et
al
chaung
et
al
tnfa
de
greeff
et
al
ifna
durand
et
al
serial
dilut
pgemt
easi
plasmid
contain
pcr
fragment
interest
use
intern
standard
c
valu
test
cytokin
sampl
express
cdna
quantiti
ng
use
intern
standard
subsequ
cytokin
level
normal
ng
level
hous
keep
gene
rrna
data
express
fold
induct
compar
control
group
statist
analys
compar
flow
cytometri
data
adv
serolog
group
perform
sampl
point
use
oneway
anova
test
use
homogen
varianc
group
statist
analys
compar
viru
load
prrsv
serolog
ifng
elispot
cytokin
rna
level
group
perform
sampl
point
use
nonparametr
kruskalw
test
follow
mannwhitney
u
test
multipl
comparison
statist
analysi
compar
data
advimmun
nonimmun
pig
within
group
perform
use
student
ttest
calcul
perform
spss
spss
inc
differ
consid
statist
signific
p
gener
differ
prrsvinfect
anim
advimmun
nonimmun
fever
clinic
sign
viral
rna
load
prrsv
antibodi
level
ifng
secret
cell
frequenc
immun
cell
blood
therefor
result
section
distinct
made
describ
paramet
immun
nonimmun
pig
differ
observ
clinic
sign
bodi
temperatur
pig
infect
lena
strain
pig
infect
belgium
lv
strain
fig
b
lenainfect
pig
show
fever
day
pi
one
belgium
ainfect
pig
day
pi
none
lvinfect
pig
fig
clinic
sign
observ
lenainfect
pig
day
pi
fig
anim
display
reduc
liveli
appetit
increas
breath
frequenc
cough
day
pi
belgium
ainfect
group
one
pig
develop
red
color
skin
ear
day
pi
show
fever
clinic
sign
relat
prrsv
infect
group
lvinfect
pig
one
pig
show
clinic
score
day
pi
found
dead
next
day
postmortem
examin
show
caus
death
intraabdomin
testicular
torsion
infarct
thu
mortal
prrsv
relat
clinic
sign
score
pig
day
pi
remov
analysi
viru
isol
pam
cell
perform
serum
inocul
pig
show
infecti
viru
detect
serum
almost
prrsv
inocul
pig
day
pi
tabl
day
pi
less
pig
infect
belgium
lv
strain
still
viraem
contrast
lenainfect
pig
anim
viraem
day
pi
day
pi
pig
clear
infect
blood
one
lenainfect
one
belgium
infect
pig
remain
viraem
four
nonadv
immun
pig
remain
experi
day
pi
serum
sampl
also
titrat
viru
titrat
assay
show
peak
viru
titer
lenainfect
pig
tcid
ml
higher
pig
infect
belgium
lv
strain
tcid
ml
tcid
ml
respect
fig
qrtpcr
perform
serum
inocul
anim
reveal
data
compar
viru
titrat
although
level
viral
rna
serum
lvinfect
pig
tcid
ml
higher
serum
belgium
ainfect
pig
tcid
ml
fig
antibodi
prrsv
detect
infect
group
day
pi
fig
antibodi
detect
control
group
signific
differ
antibodi
level
strain
day
pi
neutral
antibodi
detect
three
infect
group
data
shown
highest
number
ifng
secret
cell
homolog
prrsv
stimul
observ
pig
infect
belgium
strain
peak
mean
ifng
pbmc
fig
lowest
number
ifng
secret
cell
observ
control
pig
lenainfect
pig
maximum
mean
ifng
pbmc
respect
group
significantli
differ
pig
infect
lv
strain
significantli
higher
number
ifng
secret
cell
control
pig
day
pi
mean
ifng
pbmc
day
pi
ifng
pbmc
day
compar
ifng
pbmc
day
pi
ifng
sc
pbmc
day
pi
control
pig
effect
infect
number
immun
cell
blood
pronounc
lenainfect
pig
fig
number
helper
cell
gd
cell
significantli
lower
lenainfect
pig
control
pig
also
observ
belgium
ainfect
pig
although
level
decreas
extent
lenainfect
pig
memori
helper
cell
level
also
lower
lenainfect
pig
compar
control
pig
follow
increas
also
observ
belgium
strain
effect
less
pronounc
lvinfect
pig
show
decreas
increas
memori
helper
cell
end
experi
number
nk
cell
infect
group
increas
inocul
significantli
higher
control
pig
lvinfect
pig
day
pi
belgium
ainfect
pig
day
pi
lvinfect
pig
show
increas
cytotox
cell
end
experi
compar
control
pig
initi
signific
decreas
observ
number
b
cell
infect
group
compar
control
pig
number
b
cell
increas
significantli
higher
level
lv
belgium
ainfect
pig
end
experi
strain
show
signific
increas
monocyt
day
pi
compar
control
pig
gener
signific
induct
cytokin
mrna
blood
cell
detect
lena
belgium
ainfect
pig
within
first
week
inocul
fig
signific
induct
cytokin
mrna
level
observ
lvinfect
pig
compar
control
pig
signific
regul
mrna
observ
lena
fold
belgium
strain
fold
day
pi
compar
control
ifna
mrna
lena
fold
belgium
fold
ifng
lena
fold
belgium
fold
lena
fold
belgium
fold
lena
fold
belgium
fold
upregul
observ
day
pi
day
pi
also
signific
increas
tnfa
mrna
blood
lenainfect
pig
fold
compar
control
interestingli
end
trial
day
pi
increas
ifng
mrna
blood
belgium
fold
lvinfect
pig
fold
blood
lenainfect
pig
follow
adv
immun
antibodi
detect
serum
pig
infect
belgium
lv
strain
control
pig
day
pi
fig
serum
pig
infect
lena
strain
antibodi
detect
one
sampl
point
later
day
pi
time
antibodi
titer
pig
infect
lena
strain
significantli
lower
log
group
control
pig
log
pig
infect
lv
log
belgium
log
studi
pathogen
immun
respons
three
european
type
prrsv
strain
compar
infect
subtyp
strain
lena
result
clinic
sign
contrast
infect
subtyp
strain
induc
fever
clinic
sign
previou
studi
strain
convent
pig
clinic
sign
sever
present
studi
pig
die
within
week
postinocul
karniychuk
et
al
sever
clinic
sign
death
pig
studi
might
due
secondari
infect
sinc
arcanobacterium
pyogen
sui
isol
lung
two
pig
use
pig
farm
specificpathogenfre
statu
pig
kept
anim
biosafeti
level
condit
would
prevent
introduct
infecti
agent
could
explain
differ
clinic
outcom
studi
although
exclud
differ
sever
clinic
sign
caus
factor
differ
pig
breed
lewi
et
al
fever
observ
pig
infect
lena
strain
pig
around
time
higher
viru
load
peak
infect
higher
cytokin
level
blood
mainli
tnfa
compar
strain
relationship
tnfa
productionrespons
blood
pathogen
prrsv
strain
demonstr
liu
et
al
describ
highli
pathogen
american
genotyp
prrsv
strain
induc
fever
clinic
sign
induc
higher
level
tnfa
blood
earli
infect
deriv
strain
lower
virul
liu
et
al
also
replic
faster
higher
titer
strain
higher
viru
replic
like
mean
trigger
innat
immun
defenc
cytokin
product
inflamm
result
fever
level
ifng
secret
cell
use
measur
effici
adapt
cellular
immun
respons
level
ifng
secret
cell
remain
low
pig
infect
lena
strain
pig
infect
denot
signific
differ
p
lena
belgium
ainfect
pig
b
lena
lvinfect
pig
c
lena
control
pig
belgium
lvinfect
pig
e
belgium
control
pig
f
lv
control
pig
belgium
day
pi
lv
strain
day
pi
increas
ifng
secret
cell
observ
compar
control
pig
would
indic
subtyp
strain
belgium
lv
induc
cellmedi
immun
respons
contrast
pig
infect
lena
strain
interestingli
level
ifng
secret
cell
belgium
ainfect
pig
high
maximum
averag
ifng
secret
pbmc
compar
lv
strain
maximum
averag
ifng
secret
pbmc
studi
european
american
genotyp
strain
show
level
lower
ifng
secret
pbmc
day
pi
diaz
et
al
batista
et
al
clear
level
ifng
secret
cell
belgium
ainfect
pig
high
besid
stronger
induct
ifng
respons
vivo
also
possibl
belgium
strain
stronger
abil
stimul
cell
vitro
elispot
assay
observ
strain
previous
et
al
strain
viru
could
isol
day
pi
peak
day
pi
decreas
strongli
day
pi
decreas
viremia
increas
nk
cell
observ
mainli
belgium
lv
strain
could
relat
viral
clearanc
besid
role
nk
cell
viru
clear
cytotox
cell
might
involv
clear
end
experi
cytotox
cell
higher
control
pig
infect
group
day
pi
although
significantli
higher
lvinfect
pig
higher
level
cytotox
cell
coincid
peak
ifng
secret
cell
increas
observ
cytotox
cell
level
could
partli
relat
clonal
expans
prrsvspecif
cell
although
increas
could
also
due
homeostat
regul
infect
inflamm
relationship
viral
clearanc
cytotox
cell
previous
observ
pig
infect
european
american
genotyp
strain
lamontagn
et
al
mezlaguna
et
al
howev
other
fail
show
high
cell
exert
ctl
activ
toward
lvinfect
alveolar
macrophag
coster
et
al
studi
determin
whether
prrsvspecif
cytotox
cell
activ
vivo
involv
viral
clearanc
describ
prrsv
polyclon
activ
b
cell
occur
mainli
lymphoid
organ
lamontagn
et
al
diaz
et
al
mobil
cell
tissu
may
explain
decreas
frequenc
b
cell
blood
infect
pig
activ
b
cell
lymph
node
could
result
product
prrsvspecif
antibodi
detect
blood
day
pi
last
week
experi
day
pi
level
b
cell
infect
pig
higher
control
pig
point
level
prrsvspecif
antibodi
also
peak
similar
cours
b
cell
level
blood
observ
previous
shi
et
al
other
howev
observ
either
increas
decreas
cell
least
week
infect
european
genotyp
strain
diaz
et
al
mezlaguna
et
al
although
studi
higher
level
b
cell
observ
infect
pig
control
pig
end
experi
contribut
viral
clearanc
product
neutral
antibodi
absenc
neutral
antibodi
observ
infect
european
genotyp
strain
diaz
et
al
howev
other
found
neutral
antibodi
lelystad
strain
around
week
pi
differ
result
attribut
differ
viru
neutral
test
method
therefor
rule
small
amount
neutral
antibodi
day
pi
level
remain
detect
limit
viru
neutral
test
use
mani
viral
infect
swine
influenza
porcin
coronaviru
van
reeth
et
al
rapid
product
type
ifn
ifnab
innat
immun
respons
supress
initi
viral
replic
promot
adapt
immun
respons
kimman
et
al
prrsv
shown
vitro
type
ifn
respons
suppress
aitali
et
al
howev
conflict
report
prrsv
inhibit
induc
type
ifn
respons
vivo
van
reeth
et
al
mezlaguna
et
al
present
studi
increas
ifna
mrna
blood
observ
day
pi
lena
belgium
ainfect
pig
parallel
viral
load
increas
level
ifna
mrna
product
observ
group
lvinfect
pig
result
differ
strain
ifna
induct
describ
occur
vitro
studi
infect
porcin
alveolar
macrophag
differ
prrsv
strain
lee
et
al
differ
infectionrepl
kinet
strain
combin
shortliv
natur
mrna
blood
pig
larg
number
gd
cell
circul
blood
cell
describ
play
role
innat
adapt
immun
respons
viral
bacteri
infect
gerner
et
al
gamma
delta
cell
act
antigen
present
cell
induc
cytotox
respons
regulatori
function
demonstr
mice
human
gerner
et
al
infect
prrsv
respond
prolifer
product
ifng
olin
et
al
present
studi
level
gd
cell
decreas
significantli
lower
level
control
pig
lena
belgium
ainfect
pig
peak
viremia
level
return
normal
belgium
ainfect
pig
day
pi
similar
cours
belgium
ainfect
pig
level
gd
cell
observ
infect
american
genotyp
strain
shi
et
al
howev
lenainfect
pig
level
gd
cell
remain
low
end
experi
day
pi
role
cell
innat
adapt
respons
could
result
increas
suscept
decreas
respons
secondari
infect
observ
lower
respons
lenainfect
pig
immun
adv
gener
concept
prrsv
immunosuppress
agent
howev
contradict
result
immunomodul
effect
prrsv
de
bruin
et
al
murtaugh
et
al
suradhat
et
al
jung
et
al
contradict
result
could
amongst
thing
caus
differ
viru
strain
use
current
studi
adv
immun
use
studi
effect
prrsv
strain
humor
immun
respons
anoth
antigen
shown
infect
lena
influenc
develop
antibodi
respons
adv
contrast
infect
lv
belgium
strain
result
lv
strain
agreement
result
de
bruin
et
al
also
show
effect
lv
strain
infect
antibodi
develop
adv
virul
strain
like
lena
shown
infect
suppress
immun
system
infect
american
genotyp
isol
caus
clinic
sign
result
classic
swine
fever
viru
vaccin
failur
increas
diseas
secondari
infect
porcin
respiratori
coronaviru
suradhat
et
al
jung
et
al
present
studi
mechan
behind
delay
adv
antibodi
respons
pig
infect
lena
strain
might
lower
level
helper
cell
gd
cell
b
cell
blood
lena
infect
pig
first
immun
day
pi
possibl
result
lower
level
effector
cell
present
studi
show
differ
immun
respons
three
differ
european
genotyp
prrsv
strain
howev
gener
pictur
similar
european
genotyp
strain
late
adapt
immun
respons
detect
neutral
antibodi
especi
lena
strain
low
level
ifng
secret
cell
diaz
et
al
mezlaguna
et
al
virul
strain
seem
mostli
affect
cell
popul
cytokin
level
blood
although
sever
mechan
behind
differ
virul
discuss
studi
cell
popul
cytokin
product
tissu
provid
insight
mechan
behind
immun
modul
differ
viru
strain
knowledg
immun
modul
prrsv
aid
develop
intervent
strategi
improv
vaccin
therapeut
agent
